Citrus Sinensis ID: 040403

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620---
MSNQIRASSSLIRRLKQQMSNPAVLIQTRSFTPSEGQRPVIVHKRSLDILHDPWFNKGTAFSMTERDRLDLRGLLPPNVMSTDQQIERFMVDLKRLEVQARDGPTDPNALAKWRILNRLHDRNETMYYKVLIANIEEYAPIVYTPTVGLVCQNYSGLFRRPRGMYFSAEDRGEMKSMVYNWPAEQVDMIVVTDGSRILGLGDLGVQGIGIAVGKLDLYVAAAGINPQRVLPIMIDVGTTNEKLLKDPLYLGLQEHRLDGDEYVSVIDEFMEAIFTRWPNVIVQFEDFQSKWAFKLLQRYRYKYRMFNDDVQGTAGVAVAGLLGAVRAQGRSMIDFPKQKIVVAGAGSAGLGVLNAARKTMARMLGNNESAFDSARSQFWVVDAKGLITEDRENIDPDAKPFARKVNEISRQGLWEGASLVEVVQQVKPDVLLGLSAVGGLFSKEVLEAMRGSTSTRPAIFAMSNPTNNAECTPEEAFSIVGDNIIFASGSPFKDVDLGNGHIGHCNQGNNMYLFPGVGLGTLLSGSRIISDGMLQAAAECLAEYMTEEEVVKGKIYPSISSIRNITKEVAAAVVKEALEEDLAEGYRGVDARELQRFNQEELLEFVELNMWHPEYPTLVYRNE
ccHHHHHHHHHHHHHHHccccccccccccccccccccccEEEccccccccccccccccccccHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccHHHHHHHHHHcHHHHccccccccHHHHHHHHHHccccccCEEEEccccccHHHHHcccccccccEEEEEcccccccccccccccccccHHHHHHHHHcccccccccccEEEEcccccHHcccccccccccccccccHHHHHHHHHHHHHHHHHcccEEEEcccccHHHHHHHHHHHHccccEEccccccHHHHHHHHHHHHHHHHccccccccccEEEEEcccHHHHHHHHHHHHHHHHHHccccccHHHHHccEEEEEccccccccccccccccccccccccHHHcccccccccHHHHHHHccccEEEEcccccccccHHHHHHHHcccccccEEEEcccccccccccHHHHHHHccccCEEEEccccccEEccccCEEcccccccEECccHHHHHHHHcccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHccccHHHHHHHHHHccccccccccccccc
**************************************PVIVHKRSLDILHDPWFNKGTAFSMTERDRLDLRGLLPPNVMSTDQQIERFMVDLKRLEVQ*RD**TDPNALAKWRILNRLHDRNETMYYKVLIANIEEYAPIVYTPTVGLVCQNYSGLFRRPRGMYFSAEDRGEMKSMVYNWPAEQVDMIVVTDGSRILGLGDLGVQGIGIAVGKLDLYVAAAGINPQRVLPIMIDVGTTNEKLLKDPLYLGLQEHRLDGDEYVSVIDEFMEAIFTRWPNVIVQFEDFQSKWAFKLLQRYRYKYRMFNDDVQGTAGVAVAGLLGAVRAQGRSMIDFPKQKIVVAGAGSAGLGVLNAARKTMARMLGNNESAFDSARSQFWVVDAKGLITEDRENIDPDAKPFARKVNEISRQGLWEGASLVEVVQQVKPDVLLGLSAVGGLFSKEVLEAMRGSTSTRPAIFAMSNPTNNAECTPEEAFSIVGDNIIFASGSPFKDVDLGNGHIGHCNQGNNMYLFPGVGLGTLLSGSRIISDGMLQAAAECLAEYMTEEEVVKGKIYPSISSIRNITKEVAAAVVKEALEEDLAEGYRGVDARELQRFNQEELLEFVELNMWHPEYPTLV****
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSNQIRASSSLIRRLKQQMSNPAVLIQTRSFTPSEGQRPVIVHKRSLDILHDPWFNKGTAFSMTERDRLDLRGLLPPNVMSTDQQIERFMVDLKRLEVQARDGPTDPNALAKWRILNRLHDRNETMYYKVLIANIEEYAPIVYTPTVGLVCQNYSGLFRRPRGMYFSAEDRGEMKSMVYNWPAEQVDMIVVTDGSRILGLGDLGVQGIGIAVGKLDLYVAAAGINPQRVLPIMIDVGTTNEKLLKDPLYLGLQEHRLDGDEYVSVIDEFMEAIFTRWPNVIVQFEDFQSKWAFKLLQRYRYKYRMFNDDVQGTAGVAVAGLLGAVRAQGRSMIDFPKQKIVVAGAGSAGLGVLNAARKTMARMLGNNESAFDSARSQFWVVDAKGLITEDRENIDPDAKPFARKVNEISRQGLWEGASLVEVVQQVKPDVLLGLSAVGGLFSKEVLEAMRGSTSTRPAIFAMSNPTNNAECTPEEAFSIVGDNIIFASGSPFKDVDLGNGHIGHCNQGNNMYLFPGVGLGTLLSGSRIISDGMLQAAAECLAEYMTEEEVVKGKIYPSISSIRNITKEVAAAVVKEALEEDLAEGYRGVDARELQRFNQEELLEFVELNMWHPEYPTLVYRNE

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
NAD-dependent malic enzyme 1, mitochondrial Involved in the regulation of sugars and amino acids metabolisms during the night period.confidentQ9SIU0
NAD-dependent malic enzyme 62 kDa isoform, mitochondrial probableP37221
NAD-dependent malic enzyme 65 kDa isoform, mitochondrial probableP37224

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
1.-.-.-Oxidoreductases.probable
1.1.-.-Acting on the CH-OH group of donors.probable
1.1.1.-15-hydroxyprostaglandin dehydrogenase (NAD(+)).probable
1.1.1.39Malate dehydrogenase (decarboxylating).probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 1GQ2, chain A
Confidence level:very confident
Coverage over the Query: 45-97,108-621
View the alignment between query and template
View the model in PyMOL
Template: 1QR6, chain A
Confidence level:confident
Coverage over the Query: 44-566
View the alignment between query and template
View the model in PyMOL